TELK -- Telik, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TELK -- Telik, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: zeta1961 who wrote (831)	1/10/2007 1:24:25 PM
From: former_pgs	Read Replies (2) of 887

>a dual aurora kinase inhibitor< Just to add... What I heard was that it is a dual inhibitor of Aurora Kinase and VEGF-R2. Whether it inhibited both A and B types of Aurora Kinase was not clarified, or I missed it. Funny combination for a dual inhibitor. I was hoping that they would change A-5 to a survival trial. Wick mentioned that they will increase the enrollment in this trial... I hope that isn't a way to dilute out the possible discordances without fixing them at the source. That would just be dumb.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next